Jade Biosciences, Inc. Current Assets
Jade Biosciences, Inc. (JBIO) had Current Assets of $471.25 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-10
- 2026-06-30: Assets, Current $471.25M.
- 2026-03-31: Assets, Current $318.52M.
- 2025-12-31: Assets, Current $348.82M.
- 2025-09-30: Assets, Current $201.36M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $471.25M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $318.52M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $348.82M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $201.36M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $222.98M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $77.37M 10-Q · filed 2025-04-25 | |
| 2024-12-31 | $69.65M 10-K · filed 2026-03-06 | $80.12M 10-K · filed 2025-03-27 |
| 2024-09-30 | $90.61M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $110.76M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $103.24M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $124.23M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $137.60M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $152.47M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $120.57M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $131.50M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $145.16M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $153.45M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $165.88M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $174.33M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $183.10M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $59.31M 10-Q · filed 2021-08-16 | |
| 2020-12-31 | $4.68M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |